£101k
vs Jul 2025Active15854435Private limited companyLondon
EPIOME AI LTD
Significant control: Rowan Patrick Rimington (25–50%), Yihan Li (25–50%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Epiome AI Ltd: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
Coming soon · product and service lists
What does Epiome AI Ltd sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01
Summary
EPIOME AI LTD is an active private limited company (company number 15854435) incorporated on 23 July 2024, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 31 July 2026, showing net assets of £101k and cash of £1.03m, with 2 employees on average. Net assets rose 726% on the prior period (−£16k).
Peer position · net assets
By net assets it sits in the top quarter of 603 comparable companies in London (median £440, upper quartile £92k).
02
Ownership and control
- Dr Rowan Patrick Rimington
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
- Dr Yihan Li
- owns 25–50% of shares
- holds 25–50% of voting rights
- can appoint or remove directors
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
03
Key dates
- Incorporated
- 23 July 20242 yrs ago
- Next accounts due
- 30 April 2028in 553 days
- Confirmation statement due
- 6 August 2027in 285 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
04
Activity
- SIC 72110
- Research and experimental development on biotechnology
- SIC 72190
- Other research and experimental development on natural sciences and engineering
- Accounts type
- Total Exemption Full
- Size band
- MicroCompanies Act thresholds
05
Financials
£1.03m
+1479%vs Jul 2025Not reported
2
No changevs Jul 2025| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 31 July 2026 | £101k | £1.03m | £65k | — | — | — | 2 |
| 31 July 2025 | −£16k | £65k | £640 | — | — | — | 2 |
Cash per employee£513kCash ÷ average employees
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
06
Filing and accounts signals
- Net assets above zeroNet assets £101,188 at 31 July 2026
- Net assets up 10% or more on the prior period+725.7% vs prior period
- Cash at bank of £50,000 or moreCash £1,025,889
- Incorporated two to five years agoIncorporated 23 July 2024
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
07
Timeline
- Next accounts duein 553 days
- Confirmation statement duein 285 days
- Accounts period endNet assets £101k · small accounts
- Accounts period endNet liabilities £16k · small accounts
- Incorporated
08
Similar companies in London
- UKAAA LTDLondon · inc. Jul 2024
- CLINICAL RESEARCH CONSULTANT LTD.London · inc. Jul 2024
- AUREUM TECHNOLOGIES LIMITEDLondon · inc. Jul 2024
- SONIC THERAPEUTICS LIMITEDLondon · inc. Jul 2024
- SHADELESS BIOTECHNOLOGY LTDLondon · inc. Jul 2024
- RENALDEE LTDLondon · inc. Jul 2024
All companies incorporated on 23 July 2024 · in Jul 2024.
09
Reminders for EPIOME AI LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.